Stock Report

Download full stock data and analysis for free Last Updated: 29-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Cymabay Therapeu (CBAY) Key Ratios

Stock Card factsheet share-fund-plan-icon

$32.48

$0.00 (0.00%)

As on 25-Mar-2024 09:30EDT

Market cap

info icon

$3,728 Mln

Revenue (TTM)

info icon

$31 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

12.8

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- 0.18 -- 42.94
EBIT -31.08 -81.02 -5.23 -42.93 -8.67
Net Profit -23.67 -15.18 11.00 -160.27 -14.36
EPS -23.67 4.38 24.20 -18.71 2.72
Book Value -- -- 571.09 10.06 -1.26
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsDec-23Dec-22Dec-21
EBIT-Margin info -313.71-313.71-327.23-300.20--
Net Margin info -27,898.82-19,603.03---359.92-55,437.72
Return on equity info -90.66-71.77-64.17-140.62-67.17
Return on Capital info -57.36-51.66-39.48-76.31-56.29
Return on Assets info -52.54-47.36-36.55-69.09-51.99
Debt to Equity (x) info ----0.392.510.39

Profitability

View Detailed Peer Comparison

ROCE

-39.48

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Cymabay Therapeu (CBAY)
-39.48
-76.31
-56.29
-29.23
-56.97
Peer Median
--
--
--
--
--
ROE

-64.17

--

Profit after tax / Average Net worth * 100

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Cymabay Therapeu (CBAY)
-64.17
-140.62
-67.17
-29.58
-57.31
Peer Median
--
--
--
--
--
ROA

-36.55

--

Profit after tax / Average Total assets * 100

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Cymabay Therapeu (CBAY)
-36.55
-69.09
-51.99
-27.07
-52.10
Peer Median
--
--
--
--
--
EBIT Margin

-327.23

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Cymabay Therapeu (CBAY)
-327.23
-300.20
--
--
--
Peer Median
--
--
--
--
--
Net Margin

-339.10

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Cymabay Therapeu (CBAY)
-339.10
-359.92
-55,437.72
-3,011.45
--
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

0.00

--

Year on year growth in net sales

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Cymabay Therapeu (CBAY)
0.00
--
--
--
--
Peer Median
--
--
--
--
--
EBIT Growth

-9.20

--

Year on year growth in operating profit (EBIT)

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Cymabay Therapeu (CBAY)
-9.20
-6.31
-66.50
51.36
-50.62
Peer Median
--
--
--
--
--
Net Profit Growth

11.37

--

Year on year growth in profit after tax

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Cymabay Therapeu (CBAY)
11.37
-28.42
-90.24
52.40
-40.92
Peer Median
--
--
--
--
--
EPS Growth

0.26

--

Year on year growth in earnings per share

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Cymabay Therapeu (CBAY)
0.26
-0.04
-0.85
0.54
-0.22
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

0.39

--

Total debt / Net worth

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Cymabay Therapeu (CBAY)
0.39
2.51
0.39
0.01
0.01
Peer Median
--
--
--
--
--
Short term debt to equity ratio

0.03

--

(Short term borrowings / Net worth)

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Cymabay Therapeu (CBAY)
0.03
0.02
0.00
0.00
0.00
Peer Median
--
--
--
--
--
Current Ratio

10.96

--

Current Assets / Current Liabilities and Provisions

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Cymabay Therapeu (CBAY)
10.96
8.94
10.41
15.38
11.51
Peer Median
--
--
--
--
--
Quick Ratio

--

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Cymabay Therapeu (CBAY)
--
--
--
--
--
Peer Median
--
--
--
--
--
Interest Coverage

-5.37

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Cymabay Therapeu (CBAY)
-5.37
-6.25
-33.91
-32.55
--
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

--

--

Debtors outstanding / Net Sales * 100

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Cymabay Therapeu (CBAY)
--
9.38
--
--
--
Peer Median
--
--
--
--
--
Asset Turnover

0.11

--

Sales / Average Total Assets

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Cymabay Therapeu (CBAY)
0.11
0.18
--
--
--
Peer Median
--
--
--
--
--
Receivable days

34.19

--

Average Debtors / Sales * 365

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Cymabay Therapeu (CBAY)
34.19
34.26
--
--
--
Peer Median
--
--
--
--
--
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Cymabay Therapeu (CBAY)
--
--
--
--
--
Peer Median
--
--
--
--
--
Payable days

1,320.48

--

Average Creditors / Cost of goods sold * 365

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Cymabay Therapeu (CBAY)
1,320.48
983.60
785.45
790.03
1,021.79
Peer Median
--
--
--
--
--
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Cymabay Therapeu (CBAY)
--
--
--
--
--
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

-23.76

--

Current share price divided by earning per share in the last twelve months

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Cymabay Therapeu (CBAY)
-23.76
-4.64
-2.59
-8.14
-1.28
Peer Median
--
--
--
--
--
Price / Book Value

8.57

--

Current share price divided by book value per share in the latest financial year

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Cymabay Therapeu (CBAY)
8.57
15.26
1.81
2.78
0.70
Peer Median
--
--
--
--
--
EV/EBITDA

-22.02

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
Cymabay Therapeu (CBAY)
-22.02
-5.57
-1.21
-4.71
0.59
Peer Median
--
--
--
--
--
loading...
loading...